The Post-GWAS Era: From Association to Function

2018/05/01 by Michael D. Gallagher, Alice S. Chen-Plotkin, Alice Chen‐Plotkin · 31 citations
Biochemistry, Genetics and Molecular Biology · #Genetic Associations and Epidemiology #Epigenetics and DNA Methylation #Bioinformatics and Genomic Networks

paper · pdf · doi:10.1016/j.ajhg.2018.04.002

Cited by

• Genome-wide association studies and transcriptomics reveal mechanisms explaining the diversity of wheat root responses to nutrient availability
• Revisiting a GWAS peak in Arabidopsis thaliana reveals possible confounding by genetic heterogeneity
• Predicting the functional impact of single nucleotide variants in <i>Drosophila melanogaster</i> with FlyCADD
• Transcriptome‐wide association study identifies the ZmbZIP89–ZmSAUR21 module as a key regulator of root growth and drought tolerance in maize
• Bridging the variant-to-function gap in type 2 diabetes: advances and challenges
• Turning genome-wide association study findings into opportunities for drug repositioning
• A scientometric review of genome-wide association studies. [europepmc]
• Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. [europepmc]
• Opportunities and challenges for transcriptome-wide association studies. [europepmc]
• High-throughput identification of human SNPs affecting regulatory element activity. [europepmc]
• QTLbase: an integrative resource for quantitative trait loci across multiple human molecular phenotypes. [europepmc]
• Brain cell type-specific enhancer-promoter interactome maps and disease - risk association. [europepmc]
• Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. [europepmc]
• Interpretation of risk loci from genome-wide association studies of Alzheimer's disease. [europepmc]
• CRISPR-based functional genomics for neurological disease. [europepmc]
• Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond. [europepmc]
• Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases. [europepmc]
• Pleiotropy and Cross-Disorder Genetics Among Psychiatric Disorders. [europepmc]
• Seven myths of how transcription factors read the cis-regulatory code. [europepmc]
• Regulatory genomic circuitry of human disease loci by integrative epigenomics. [europepmc]
• Genetic impacts on DNA methylation: research findings and future perspectives. [europepmc]
• Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis. [europepmc]
• Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals. [europepmc]
• Using Phecodes for Research with the Electronic Health Record: From PheWAS to PheRS. [europepmc]
• Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits. [europepmc]
• TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. [europepmc]
• Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. [europepmc]
• Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity. [europepmc]
• Alzheimer's Disease: An Updated Overview of Its Genetics. [europepmc]
• Leveraging base-pair mammalian constraint to understand genetic variation and human disease. [europepmc]
• Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. [europepmc]